Renal vein thrombosis is a rare condition of neonatal age. Its incidence is low, 2.2 per 100,000 live births.
The consequences of the disease are common and quite serious. Due to the low incidence of the disease, there are no clear and consistent therapeutic recommendations in literature based on randomized trials.
In this article, the authors present their experience with invasive treatment of this disease in the four-day newborn.